Sentinus, LLC Abbott Laboratories Transaction History

Sentinus, LLC

$415 Million
Q3 2025

A detailed history of Sentinus, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sentinus, LLC holds 20,830 shares of ABT stock, worth $2.71 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

20,830

Previous 16,774 24.18%

Holding current value

$2.71 Million

Previous $2.28 Million 22.27%

% of portfolio

0.67%

Previous 0.62%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$120.51 - $136.62 $488,788 - $554,130	4,056 Added 24.18%	20,830 $2.79 Million
Q2 2025 Aug 13, 2025	BUY	$123.95 - $138.08 $71,519 - $79,672	577 Added 3.56%	16,774 $2.28 Million
Q1 2025 May 15, 2025	BUY	$111.1 - $140.22 $9,221 - $11,638	83 Added 0.52%	16,197 $2.15 Million
Q4 2024 Feb 13, 2025	BUY	$111.93 - $119.39 $25,184 - $26,862	225 Added 1.42%	16,114 $1.82 Million
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $900 - $1,063	-9 Reduced 0.06%	15,889 $1.81 Million

Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $82,598 - $92,200	820 Added 5.44%	15,898 $1.65 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $8,542 - $9,434	-78 Reduced 0.51%	15,078 $1.71 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $14,613 - $16,282	-145 Reduced 0.95%	15,156 $1.65 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $959,592 - $1.13 Million	9,907 Added 183.67%	15,301 $1.55 Million
Q4 2022 Feb 15, 2023	SELL	$95.06 - $111.52 $913,906 - $1.07 Million	-9,614 Reduced 64.06%	5,394 $592,000
Q3 2022 Nov 16, 2022	BUY	$96.76 - $112.03 $1.45 Million - $1.68 Million	15,008 New	15,008 $1.45 Million

Others Institutions Holding ABT

# of Institutions

3,651

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentinus, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentinus, LLC with notifications on news.

Account